Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 2
2021 1
2022 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages.
Manara MC, Manferdini C, Cristalli C, Carrabotta M, Santi S, De Feo A, Caldoni G, Pasello M, Landuzzi L, Lollini PL, Salamanna F, Dominici S, Fiori V, Magnani M, Lisignoli G, Scotlandi K. Manara MC, et al. Among authors: cristalli c. Cancer Immunol Res. 2024 Feb 2;12(2):247-260. doi: 10.1158/2326-6066.CIR-23-0440. Cancer Immunol Res. 2024. PMID: 38051221 Free PMC article.
Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma.
Zoumpoulidou G, Alvarez-Mendoza C, Mancusi C, Ahmed RM, Denman M, Steele CD, Tarabichi M, Roy E, Davies LR, Manji J, Cristalli C, Scotlandi K, Pillay N, Strauss SJ, Mittnacht S. Zoumpoulidou G, et al. Among authors: cristalli c. Nat Commun. 2021 Dec 3;12(1):7064. doi: 10.1038/s41467-021-27291-8. Nat Commun. 2021. PMID: 34862364 Free PMC article.
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis.
Pasello M, Giudice AM, Cristalli C, Manara MC, Mancarella C, Parra A, Serra M, Magagnoli G, Cidre-Aranaz F, Grünewald TGP, Bini C, Lollini PL, Longhi A, Donati DM, Scotlandi K. Pasello M, et al. Among authors: cristalli c. Cell Oncol (Dordr). 2022 Dec;45(6):1237-1251. doi: 10.1007/s13402-022-00713-5. Epub 2022 Sep 23. Cell Oncol (Dordr). 2022. PMID: 36149602 Free PMC article.
Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response.
Cristalli C, Manara MC, Valente S, Pellegrini E, Bavelloni A, De Feo A, Blalock W, Di Bello E, Piñeyro D, Merkel A, Esteller M, Tirado OM, Mai A, Scotlandi K. Cristalli C, et al. Front Endocrinol (Lausanne). 2022 May 31;13:876602. doi: 10.3389/fendo.2022.876602. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35712255 Free PMC article.
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy.
Manara MC, Valente S, Cristalli C, Nicoletti G, Landuzzi L, Zwergel C, Mazzone R, Stazi G, Arimondo PB, Pasello M, Guerzoni C, Picci P, Nanni P, Lollini PL, Mai A, Scotlandi K. Manara MC, et al. Among authors: cristalli c. Mol Cancer Ther. 2018 Sep;17(9):1881-1892. doi: 10.1158/1535-7163.MCT-17-0818. Epub 2018 Jun 29. Mol Cancer Ther. 2018. PMID: 29959201
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis.
Pasello M, Giudice AM, Cristalli C, Manara MC, Mancarella C, Parra A, Serra M, Magagnoli G, Cidre-Aranaz F, Grünewald TGP, Bini C, Lollini PL, Longhi A, Donati DM, Scotlandi K. Pasello M, et al. Among authors: cristalli c. Cell Oncol (Dordr). 2022 Dec;45(6):1253. doi: 10.1007/s13402-022-00735-z. Cell Oncol (Dordr). 2022. PMID: 36352194 Free PMC article. No abstract available.
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations.
Nanni P, Landuzzi L, Manara MC, Righi A, Nicoletti G, Cristalli C, Pasello M, Parra A, Carrabotta M, Ferracin M, Palladini A, Ianzano ML, Giusti V, Ruzzi F, Magnani M, Donati DM, Picci P, Lollini PL, Scotlandi K. Nanni P, et al. Among authors: cristalli c. Sci Rep. 2019 Aug 21;9(1):12174. doi: 10.1038/s41598-019-48634-y. Sci Rep. 2019. PMID: 31434953 Free PMC article.
ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
Zucchini C, Manara MC, Cristalli C, Carrabotta M, Greco S, Pinca RS, Ferrari C, Landuzzi L, Pasello M, Lollini PL, Gambarotti M, Donati DM, Scotlandi K. Zucchini C, et al. Among authors: cristalli c. J Exp Clin Cancer Res. 2019 Dec 26;38(1):503. doi: 10.1186/s13046-019-1506-3. J Exp Clin Cancer Res. 2019. PMID: 31878963 Free PMC article.